Neuronetics Inc. has released a corporate presentation outlining its recent merger with another major mental health and device company, creating a vertically integrated organization focused on expanding access to mental health treatments. The combined entity reported $129 million in annual revenue for 2024, treated 229,429 unique patients, and administered over 8.2 million treatments. The company highlighted its diversified business model, leveraging expertise in both transcranial magnetic stimulation (TMS) through its NeuroStar brand and mental health services via Greenbrook. Senior leadership includes President and CEO Keith Sullivan and Chief Financial Officer Steven Pfanstiel. You can access the full presentation through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuronetics Inc. published the original content used to generate this news brief on November 04, 2025, and is solely responsible for the information contained therein.
Comments